Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.54
-1.09 (-2.00%)
At close: Nov 4, 2024, 4:00 PM
53.75
+0.21 (0.39%)
After-hours: Nov 4, 2024, 7:55 PM EST
Moderna Revenue
Moderna had revenue of $241.00M in the quarter ending June 30, 2024, a decrease of -29.94%. This brings the company's revenue in the last twelve months to $5.05B, down -52.60% year-over-year. In the year 2023, Moderna had annual revenue of $6.85B, down -64.45%.
Revenue (ttm)
$5.05B
Revenue Growth
-52.60%
P/S Ratio
4.13
Revenue / Employee
$901,786
Employees
5,600
Market Cap
20.58B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Molina Healthcare | 37.54B |
Teva Pharmaceutical | 16.29B |
Baxter International | 15.00B |
Labcorp Holdings | 12.71B |
Zimmer Biomet Holdings | 7.60B |
STERIS | 5.23B |
Hologic | 3.99B |
The Cooper Companies | 3.80B |
MRNA News
- 4 days ago - These are the S&P 500's biggest laggards for October, down by as much as 29% - Market Watch
- 4 days ago - Moderna to Present at Upcoming Conferences in November 2024 - Accesswire
- 6 days ago - mRNA Synthesis & Manufacturing Market to Hit USD 2958.3 million by 2029 with 5.8% CAGR | MarketsandMarkets™ - GlobeNewsWire
- 7 days ago - Moderna Stock Price Target Slashed. It's About Vaccines. - Barrons
- 7 days ago - Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC) - Business Wire
- 11 days ago - Moderna Named a Top Employer by Science for Tenth Consecutive Year - Accesswire
- 13 days ago - We Think Moderna Still Has A Future - Seeking Alpha
- 18 days ago - Moderna to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 - Accesswire